Skip to main content

Reactivity of autoimmune hepatitis sera with glutathione S-transferase

  • Chapter
Immunology and Liver

Part of the book series: Falk Symposium ((FASS,volume 114))

  • 123 Accesses

Abstract

Autoimmune hepatitis (AIH)1-4, an inflammatory liver disease, represents histologically and serologically a broad spectrum of characteristic features. The classification of AIH is primarily based on serological criteria. Type I AIH is defined by antibodies to nuclei (ANA) and eventually actin, while type II AIH is characterized by antimicrosomal antibodies recognizing cytochrome P450IID62-6. Moreover, a substantial number of AIH patients7-11 produce antibodies to a cytosolic soluble antigen7-10, either alone or in combination with antinuclear and/or smooth muscle antibodies (SMA). One may assume that these patients represent a distinct AIH subgroup. However, two different cytosolic antigens have been described: liver-pancreas-specific antigen (LP)12 and soluble liver antigen (SLA)7. From originally described characteristics and a careful comparison of the isolation procedure it can be deduced that the antigens are identical. Both antigens were defined as non-species-, non-organ-specific, despite their highest concentration being in the liver. According to the published protocols they were obtained as a supernatant after extensive ultracentrifugation of the tissue9 homogenates, indicating their extremely high solubility. Moreover, both antigens represent a very heterogeneous fraction, consisting of at least 100 different proteins. Therefore, one might expect that human autoantibodies would exhibit specificity against more than a single antigen target.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mackay IR, Taft CO, Cowling DS. Lupoid hepatitis. Lancet. 1956;2:1323–1326.

    Article  Google Scholar 

  2. Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci. 1995;40:435–456.

    Article  PubMed  CAS  Google Scholar 

  3. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588–598.

    PubMed  CAS  Google Scholar 

  4. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 1996;334:897–903.

    Article  PubMed  CAS  Google Scholar 

  5. Smith MGM, Williams R, Walker R, Rizzetto M, Doniach D. Hepatic disorders associated with liver/kidney microsomal antibodies. Br Med J. 1974;2:80–84.

    Article  PubMed  CAS  Google Scholar 

  6. Homberg JC, Abuaf N, Bernard O et al. Chronic active hepatitis associated with anti-liver-kidney microsome antibody type 1: a second type of ‘autoimmune’ hepatitis. Hepatology. 1987;7:1333–1339.

    Article  PubMed  CAS  Google Scholar 

  7. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde KH. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet. 1987;1:292–294.

    Article  PubMed  CAS  Google Scholar 

  8. Johnson PI, McFarlane IG, McFarlane BM, Williams R. Autoimmune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional autoantibodies. J Gastroenterol Hepatol. 1990;5:244–251.

    Article  PubMed  CAS  Google Scholar 

  9. Johnson PI, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998–1005.

    Article  PubMed  CAS  Google Scholar 

  10. Czaja AJ, Carpenter HA, Manns MR Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology. 1993;105:1522–1528.

    Article  PubMed  CAS  Google Scholar 

  11. McFarlane JG, Williams R. Historical overview. In: McFarlane JG, Williams R, editors. Molecular Basis of Autoimmune Hepatitis. Heidelberg: Springer-Verlag. 1996:1–21.

    Google Scholar 

  12. Stechenmesser E, Strienz J, Berg PA. Serological definition of a new subgroup of patients with autoimmune chronic active hepatitis. Lancet. 1987;1:683.

    Article  Google Scholar 

  13. DeDuwe C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F. Tissue fractionation studies. Intracellular distribution patterns of enzymes in rat liver tissues. Biochem J. 1955;60:604–610.

    Google Scholar 

  14. Tata JR. Isolation of nuclei from rat liver and other tissues. Methods Enzymol. 1974;31:253–562.

    Article  PubMed  CAS  Google Scholar 

  15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685.

    Article  PubMed  CAS  Google Scholar 

  16. O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250:4007–4021.

    PubMed  Google Scholar 

  17. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J Exp Med. 1995;182:1159–1162.

    Article  PubMed  CAS  Google Scholar 

  18. Simons PC, Vander Jagt DL. Purification of glutathione S-transferases from human liver by glutathione-affinity chromatography. Analyt Biochem. 1977;82:334–341.

    Article  PubMed  CAS  Google Scholar 

  19. Wächter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum Büschenfelde KH, Manns M. Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol. 1990;11:232–239.

    Article  PubMed  Google Scholar 

  20. Franke WW, Schiller D, Moll R, Winter S, Schmid E, Engelbrecht I. Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol. 1981;153:933–959.

    Article  PubMed  CAS  Google Scholar 

  21. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultures cells. Cell. 1982;31:11–24.

    Article  PubMed  CAS  Google Scholar 

  22. Chou Y-H, Rosevear E, Goldman RD. Phosphorylation and disassembly of intermediate filaments in mitotic cells. Proc Natl Acad Sci USA. 1989;86:1885–1889.

    Article  PubMed  CAS  Google Scholar 

  23. Stechenmesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology. 1993;18:1–9.

    Article  Google Scholar 

  24. Bass NM, Kirsch RE, Tuff SA, Marks I, Saunders SJ. Ligand in heterogeneity: evidence that the two non-identical subunits are the monomers of the two distinct proteins. Biochim Biophys Acta. 1977;492:163–175.

    Article  PubMed  CAS  Google Scholar 

  25. Hayes JD. Purification and characterization of glutathione S-transferases P, S, and N. Isolation from rat liver of Yb, Yn protein, the existence of which was predicted by subunit hybridization in vitro.Biochem J. 1984;224:839–852.

    PubMed  CAS  Google Scholar 

  26. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST* and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600.

    Article  PubMed  CAS  Google Scholar 

  27. Pickett CB, Telakowski-Hopkins CA, Ding GJ-F, Argenbright L, Lu AYH. Rat liver glutathione S-transferases. Complete nucleotide sequence of a glutathione S-transferase mRNA and the regulation of the Ya, Yb, and Yc mRNA by 3-methylcholanthrene and phenobarbital. J Biol Chem. 1984;259:5182–5188.

    PubMed  CAS  Google Scholar 

  28. Telakowski-Hopkins CA, Rodkey JA, Bennett CD, Lu AYH, Pickett CB. Rat liver glutathione S-transferases. Construction of a cDNA clone complementary to a Yc mRNA and prediction of the complete amino acid sequence of a Yc subunit. J Biol Chem. 1985;260:5820–5825.

    PubMed  CAS  Google Scholar 

  29. Smith GJ, Ohl VS, Litwack G. Ligandin, the glutathione S-transferases, and chemically induced hepatocarcinogenesis: a review. Cancer Res. 1977;37:8–14.

    PubMed  CAS  Google Scholar 

  30. Wesierska-Gadek J, Grimm R, Hitchman E, Penner E. Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology, 1996;114:329–335.

    Article  Google Scholar 

  31. Hayes PC, Portmann B, Aldis PM, Williams R, Hayes JD. In: Mantle TJ, Pickett CB, Hayes JD, editors. Glutathione S-transferases and Carcinogenesis. London: Taylor & Francis; 1987;175–187.

    Google Scholar 

  32. Mackay IR. The grey edges of autoimmune hepatitis. Intern Hepatol Commun. 1996;5:191–200.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Węsierska-Gądek, J., Penner, E. (2000). Reactivity of autoimmune hepatitis sera with glutathione S-transferase. In: Manns, M.P., Paumgartner, G., Leuschner, U. (eds) Immunology and Liver. Falk Symposium, vol 114. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4000-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4000-3_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5768-4

  • Online ISBN: 978-94-011-4000-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics